drug
ROCURONIUM BROMIDE
Marketedupdated 3mo agoby Piramal Critical Care Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6all catalysts(3)
Trials studying ROCURONIUM BROMIDE
- phase4Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery and Immune Function
- phase1Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation With Moderate vs. Deep Neuromuscular Block
- phase2Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 22, 2039
~12.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (1)
- Jul 22, 2039formulationUS 11998605
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that